Aging researchers sued

Osteopaths ask for $120 million after being criticized; experts question limits of scientific debate

Written byAdam Marcus
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Two aging-science researchers are suing two other academics for $120 million, arguing that the defendants have damaged their reputation by accusing them of making inflated claims about the efficacy of anti-aging therapies they promote, a case that raises questions about when academic debate crosses a line.

The plaintiffs in the lawsuit are Ronald M. Klatz and Robert M. Goldman, a pair of osteopaths who founded the American Academy of Anti-Aging Medicine, or A4M, in Chicago. The doctors, who also earned MD degrees in Belize, argue that their critics have defamed them as scientists and interfered with their business relationships. While A4M appears to be a clearinghouse of aging research and information, visitors to its website can quickly arrive at commercial sponsor pages selling all manner of products and services, many of questionable efficacy, according to some scientists. The two plaintiffs also have a company called Medical Development Management that sells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA